Finance News - Sanofi

All U.S. UK Canada Australia Europe India Global Crypto

No results found

Type at least 2 characters to search

Loading tags...

No matching tags found

Filter by:

Any time Past hour Past 24 hours Past week Past month Past year

All Sources ABC News Business BBC Business Business Insider Markets City A.M. CNBC Business CoinDesk Coinpedia Cointelegraph Crypto News CryptoSlate Decrypt Economic Times Markets Euronews Business Financial Post Top Stories Financial Times Globe and Mail Investing Investing.com Global Mkts Investopedia Kiplinger MarketWatch MarketPulse MarketWatch Top Stories Quartz Sky News Money Sydney Morning Herald Biz TechCrunch Fintech The Block The Guardian – Business WSJ Markets News

All Access Types Free Limited Free Subscription Required

Category Sanofi

CNBC Business • 01/29/2026 • Free

Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite

Despite disappointing annual earnings, investors remain attentive to the companies’ future development efforts and potential breakthroughs that could...

Read Full Article →

MarketWatch Top Stories • 12/15/2025 • Limited Free

Sanofi stock slumps after two setbacks on multiple-sclerosis drug

The decline in Sanofi’s share value reflects investor concerns following delays in regulatory approval and unsuccessful clinical trial results affecti...

Read Full Article →

The Guardian – Business • 09/12/2025 • Free

Britain is ‘a terrible place’ to sell medicines, says drug firm executive

A senior pharmaceutical leader emphasized the need for increased government investment in innovative therapies to improve the commercial environment a...

Read Full Article →

CNBC Business • 06/09/2025 • Free

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales...

Read Full Article →

Investopedia • 06/02/2025 • Free

Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover

The agreement for a multibillion-dollar acquisition by Sanofi has led to a notable increase in the market value of Blueprint Medicines shares.

Read Full Article →

Investopedia • 05/22/2025 • Free

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

The company's market value increased significantly after the announcement of its upcoming purchase by a major pharmaceutical firm, highlighting invest...

Read Full Article →

Price Alerts

Sign in to create alerts

Finance News - Sanofi

Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite

Sanofi stock slumps after two setbacks on multiple-sclerosis drug

Britain is ‘a terrible place’ to sell medicines, says drug firm executive

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

Featured Sources

What is your interest today?

Sign in to continue

Weekly limit reached

Export limit reached

Historical lookups used

Extended Charts - Pro Feature

Cloud Export - Pro Feature

Finance News - Sanofi

Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite

Sanofi stock slumps after two setbacks on multiple-sclerosis drug

Britain is ‘a terrible place’ to sell medicines, says drug firm executive

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

Featured Sources

What is your interest today?

Format Settings

Language

Localized Format

Decimal Format